北京红惠生物制药

Beijing Honghui Biopharmaceutical is a comprehensive pharmaceutical enterprise based in Beijing, China, specializing in the research, development, and large-scale production of chemical drugs. Founded in 1994, the company maintains a significant presence in the domestic market with a focus on therapeutic areas including cardiovascular, anti-infective, and respiratory medicine. Its facilities are GMP-certified, supporting the manufacture of both finished dosage forms and active pharmaceutical ingredients. Honghui Biopharmaceutical is recognized for its integration of R&D with commercial manufacturing to provide high-quality generic medications. The company's product portfolio includes widely used treatments for hypertension and various bacterial infections. It continues to expand its reach through strategic partnerships and a robust distribution network across China.